RL
RVNC

RPO LLC’s Revance Therapeutics, Inc. RVNC Stock Holding History

RPO LLC’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,969
Closed -$54.6K – 93
2024
Q4 		$54.6K Buy
+17,969
New +$78.3K 0.05% 51

Other funds holding RVNC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

RPO LLC's RVNC Position: Q1 2025 in Review

RPO LLC sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 17,969 shares — an estimated $54.6K sold.

RPO LLC first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $54.6K in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

  • RPO LLC reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
  • RPO LLC sold 17,969 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $54.6K.
  • RPO LLC first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
  • RPO LLC's Revance Therapeutics, Inc. position peaked at $54.6K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on RPO LLC's 13F filing for Q1 2025, filed 13 May 2025.